Navigation Links
Pharma Base S.A. Launches Osamine(TM) Pharmaceutical Grade Glucosamine in North America
Date:4/24/2008

PFAFFIKON, Switzerland, April 24 /PRNewswire/ -- Pharma Base S.A. announces the launch of Osamine(TM) Pharmaceutical Grade Glucosamine for the North American Dietary Supplement, Personal Care and Food industries. Available as both Glucosamine Hydrochloride and Glucosamine Sulphate, Osamine(TM) brings forward high quality pharmaceutical grade glucosamine to the worldwide marketplace.

"With a greater focus on ingredient quality and a strong demand for raw material sources outside of China, the North American marketplace is ready for a superior quality ingredient like Osamine(TM). Having been sold over the last decade in Europe, Japan and India, we are thrilled to introduce this ingredient to the Americas." says Russ Anderson, President of Pharma Base North America.

About Pharma Base

Pharma Base S.A., founded in 1996, is a privately-held company dedicated to improving the lives of people through the research and discovery of naturally occurring compounds. Our commitment is to manufacture and distribute clinically proven, safe and effective high-quality products manufactured in cGMP facilities, thereby helping to elevate the standards and quality of dietary supplements. The company is headquartered in Switzerland with additional locations in India and North America.
For more information:

http://www.osamine.com

http://www.pharmabase.com


'/>"/>
SOURCE Pharma Base S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Prime Hires Rachelle Wan as Vice President of Pharmaceutical Trade Relations
2. The Quigley Corporation Reports First Quarter 2008 Results - Increases Investment in Pharmaceutical R&D Future
3. Pharmacyclics Reports Third Quarter 2008 Financial Results
4. Complimentary Excerpt Available from Best Practices: Pharmaceutical Competitive Intelligence Excellence - Optimizing Data Collection within Approved Guidelines
5. Jazz Pharmaceuticals to Present at Morgan Stanley Conference
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. Medco, UnitedHealth Group Announce Pharmacy Services Agreement
8. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
9. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2008 Financial Results
10. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
11. Amylin Pharmaceuticals Reports First Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , ... April 28, 2016 , ... Head Over Heels ... 9 Western Championships. The competition will be held at the University of Montana on ... gymnasts west of the Mississippi River. , In order to qualify, Varize needed to ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... open availability of a new CDISC standard, Clinical Trial Registry (CTR) XML. ... This innovative standard will make it possible to build applications that generate ...
(Date:4/28/2016)... ... April 28, 2016 , ... Cosmetic Town, an online ... cosmetictown.com . The forum section was recently revamped and upgraded to allow even more ... in use across the country. , According to the senior editor of Cosmetic Town, ...
(Date:4/28/2016)... ... 2016 , ... Greener Hydroponics is now offering a large selection of Smart ... organic farmers and nurseries according to Sales Manager Joe Steele who says, “Now is ... is to offer wholesale level pricing and ultra-fast shipping for growers of any size.” ...
(Date:4/28/2016)... ... April 28, 2016 , ... In 2011, TIME magazine ... the emerging field of biomechatronics, technology that marries human physiology with electromechanics. He continues ... He is also the Founder of BionX , a leader in the field ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... 27, 2016 ... in Zürich gab Strekin AG den Start ... zur Erhaltung des Resthörvermögens von Patienten, denen ... die umfassende Phase-II-Doppelblindstudie mit Placebo-Kontrollgruppe werden momentan ... wird während der Operation direkt ins Mittelohr ...
(Date:4/27/2016)... PARIS , April 27, 2016 ... Year-Over-Year Including 42% Growth in Recurring Consumable Sales  ... Mauna Kea Technologies (Euronext: MKEA, OTCQX: MKEAY) ... today announced its sales for the first quarter ended ... business and the execution of its commercial strategy. ...
(Date:4/27/2016)... 2016 Transparency Market Research has ... - Global Industry Analysis, Size, Share, Growth, Trends, and ... global skincare devices market was valued at US$ 7,255.8 ... a CAGR of 10.1% from 2015 to 2023 to ... the full Skincare Devices Market (Treatment Device - LED Therapy ...
Breaking Medicine Technology: